Nova Eye Medical (AU:EYE) has released an update.
Nova Eye Medical Limited is set to enhance its financial muscle by issuing 237,490 new fully paid ordinary shares, as detailed in their recent announcement on August 2, 2024. The application for these securities to be quoted has been made to the ASX under the code EYE, signifying a potential expansion of the company’s investor base and capital.
For further insights into AU:EYE stock, check out TipRanks’ Stock Analysis page.
